Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,850 signal articles · 175 in last 24h · 124,043 total before filter · latest 39m ago
175last 24h
1200last 7d
197● bullish (7d)
133● bearish (7d)
205publishers
AllMacro212Earnings406M&A100Regulatory21Product11Analyst9
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Can Johnson Controls (JCI) Turn Wasted Heat Into $18B?
Insider Monkey14d agoneutral
Can Johnson Controls (JCI) Turn Wasted Heat Into $18B?

Johnson Controls International (NYSE:JCI) just found a way to sell power that the data center industry was throwing away. On July 28, the company launched its Absorption Chiller Reference Design Guide, a blueprint that converts waste heat from on-site generators into cooling capacity, freeing up electricity that would otherwise go to running chillers. In a […]

AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook
Insider Monkey14d agoneutral
AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook

AbCellera Biologics Inc. (NASDAQ:ABCL) rallied for a third consecutive day on Monday to hit a new three-year high, after its drug candidate for hot flashes in menopausal women achieved strong clinical trial results, sparking long-term rosy growth prospects. In intra-day trading, the stock surged to a record high of $10.01 before trimming gains to end […]

Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
Insider Monkey14d agoneutral
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?

The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution. Investors have spent the past three years comparing prescription growth, market share, and pipeline candidates as Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) compete for dominance in one of healthcare’s fastest-growing markets. Yet another competitive advantage for investors to […]

Intel (INTC) Tripled This Year, But Can a $15B Share Sale Stop the Momentum?
Insider Monkey14d agoneutral
Intel (INTC) Tripled This Year, But Can a $15B Share Sale Stop the Momentum?

Intel (NASDAQ:INTC) shares have nearly tripled this year, outrunning AMD (NASDAQ:AMD), Nvidia (NASDAQ:NVDA), and the Philadelphia Semiconductor Index’s nearly 75% climb. On August 10, the company said it would sell $15 billion of new stock to fund its push into contract chip manufacturing, and shares fell more than 4% in early trading. That marked a […]

Trump Vs. Musk: President Says EV Drivers ‘Have a Disease’
Benzinga14d agoneutral
Trump Vs. Musk: President Says EV Drivers ‘Have a Disease’

The relationship between Tesla Inc CEO Elon Musk and President Donald Trump has been mostly positive since their notorious spat last year. After all, the billionaire poured hundreds of millions of dollars into Trump’s 2024 campaign and remains a key...